世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
転移性癌治療薬の世界市場に関する洞察、2028年までの予測Global Metastatic Cancer Treat Drug Market Insights, Forecast to 2028 市場の分析と洞察。転移性癌治療薬の世界市場 COVID-19の大流行により、転移性癌治療薬の世界市場規模は2022年に百万米ドルの価値があると推定され、2022年から2028年の予測期間中に％CAGRで2028年までに百万米... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリー市場の分析と洞察。転移性癌治療薬の世界市場COVID-19の大流行により、転移性癌治療薬の世界市場規模は2022年に百万米ドルの価値があると推定され、2022年から2028年の予測期間中に％CAGRで2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年に転移性癌治療薬の世界市場の％を占めた化学療法薬は、2022年から2028年まで修正された％のCAGRで成長し、2028年までに百万米ドルを値すると予測されます。一方、病院部門は、この予測期間を通して％CAGRに変更されています。 中国転移性癌治療薬の市場規模は2021年に百万米ドル、米国と欧州転移性癌治療薬はそれぞれ百万米ドル、百万米ドルと評価されています。2021年の米国の割合は％、中国と欧州はそれぞれ％、％で、中国の割合は2028年には％に達すると予測され、分析期間2022-2028年を通じてCAGRは％であると追跡しています。日本、韓国、東南アジアはアジアの注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の転移性癌治療薬の展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間2022-2028年を通じてCAGR %を推移しています。 転移性癌治療薬の世界的な主要メーカーは、Roche、Merck、Johnson and Johnson、Eli Lilly、Sun Pharmaceutical、Bayer、Gilead Sciences、GlaxoSmithKline、Novartisなどです。2021年、世界の上位5社は売上高で約 % のシェアを占めています。 世界の転移性がん治療薬の範囲とセグメント 転移性癌治療薬市場は、タイプ別および用途別に区分されます。世界のMetastatic Cancer Treat Drug市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして使用することで、優位に立つことができるようになることでしょう。セグメント分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。 タイプ別セグメント 化学療法剤 標的治療薬 アプリケーション別セグメント 病院 クリニック その他 会社別 ロシュ メルク ジョンソン・アンド・ジョンソン イーライ・リリー サンファーマシューティカル バイエル ギリアド・サイエンス グラクソ・スミスクライン ノバルティス ファイザー アストラゼネカ 地域別 北米 米国 カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋地域 中国 日本 韓国 インド オーストラリア 中国 台湾 インドネシア タイ マレーシア 中南米 メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア UAE 目次1 Study Coverage1.1 Metastatic Cancer Treat Drug Product Introduction 1.2 Market by Type 1.2.1 Global Metastatic Cancer Treat Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Chemotherapy Drugs 1.2.3 Targeted Therapy Drugs 1.3 Market by Application 1.3.1 Global Metastatic Cancer Treat Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Metastatic Cancer Treat Drug Sales Estimates and Forecasts 2017-2028 2.2 Global Metastatic Cancer Treat Drug Revenue Estimates and Forecasts 2017-2028 2.3 Global Metastatic Cancer Treat Drug Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Metastatic Cancer Treat Drug Sales by Region 2.4.1 Global Metastatic Cancer Treat Drug Sales by Region (2017-2022) 2.4.2 Global Sales Metastatic Cancer Treat Drug by Region (2023-2028) 2.5 Global Metastatic Cancer Treat Drug Revenue by Region 2.5.1 Global Metastatic Cancer Treat Drug Revenue by Region (2017-2022) 2.5.2 Global Metastatic Cancer Treat Drug Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Metastatic Cancer Treat Drug Sales by Manufacturers 3.1.1 Global Top Metastatic Cancer Treat Drug Manufacturers by Sales (2017-2022) 3.1.2 Global Metastatic Cancer Treat Drug Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metastatic Cancer Treat Drug in 2021 3.2 Global Metastatic Cancer Treat Drug Revenue by Manufacturers 3.2.1 Global Metastatic Cancer Treat Drug Revenue by Manufacturers (2017-2022) 3.2.2 Global Metastatic Cancer Treat Drug Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Metastatic Cancer Treat Drug Revenue in 2021 3.3 Global Metastatic Cancer Treat Drug Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Metastatic Cancer Treat Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Metastatic Cancer Treat Drug Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Metastatic Cancer Treat Drug Sales by Type 4.1.1 Global Metastatic Cancer Treat Drug Historical Sales by Type (2017-2022) 4.1.2 Global Metastatic Cancer Treat Drug Forecasted Sales by Type (2023-2028) 4.1.3 Global Metastatic Cancer Treat Drug Sales Market Share by Type (2017-2028) 4.2 Global Metastatic Cancer Treat Drug Revenue by Type 4.2.1 Global Metastatic Cancer Treat Drug Historical Revenue by Type (2017-2022) 4.2.2 Global Metastatic Cancer Treat Drug Forecasted Revenue by Type (2023-2028) 4.2.3 Global Metastatic Cancer Treat Drug Revenue Market Share by Type (2017-2028) 4.3 Global Metastatic Cancer Treat Drug Price by Type 4.3.1 Global Metastatic Cancer Treat Drug Price by Type (2017-2022) 4.3.2 Global Metastatic Cancer Treat Drug Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Metastatic Cancer Treat Drug Sales by Application 5.1.1 Global Metastatic Cancer Treat Drug Historical Sales by Application (2017-2022) 5.1.2 Global Metastatic Cancer Treat Drug Forecasted Sales by Application (2023-2028) 5.1.3 Global Metastatic Cancer Treat Drug Sales Market Share by Application (2017-2028) 5.2 Global Metastatic Cancer Treat Drug Revenue by Application 5.2.1 Global Metastatic Cancer Treat Drug Historical Revenue by Application (2017-2022) 5.2.2 Global Metastatic Cancer Treat Drug Forecasted Revenue by Application (2023-2028) 5.2.3 Global Metastatic Cancer Treat Drug Revenue Market Share by Application (2017-2028) 5.3 Global Metastatic Cancer Treat Drug Price by Application 5.3.1 Global Metastatic Cancer Treat Drug Price by Application (2017-2022) 5.3.2 Global Metastatic Cancer Treat Drug Price Forecast by Application (2023-2028) 6 North America 6.1 North America Metastatic Cancer Treat Drug Market Size by Type 6.1.1 North America Metastatic Cancer Treat Drug Sales by Type (2017-2028) 6.1.2 North America Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 6.2 North America Metastatic Cancer Treat Drug Market Size by Application 6.2.1 North America Metastatic Cancer Treat Drug Sales by Application (2017-2028) 6.2.2 North America Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 6.3 North America Metastatic Cancer Treat Drug Market Size by Country 6.3.1 North America Metastatic Cancer Treat Drug Sales by Country (2017-2028) 6.3.2 North America Metastatic Cancer Treat Drug Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada 7 Europe 7.1 Europe Metastatic Cancer Treat Drug Market Size by Type 7.1.1 Europe Metastatic Cancer Treat Drug Sales by Type (2017-2028) 7.1.2 Europe Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 7.2 Europe Metastatic Cancer Treat Drug Market Size by Application 7.2.1 Europe Metastatic Cancer Treat Drug Sales by Application (2017-2028) 7.2.2 Europe Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 7.3 Europe Metastatic Cancer Treat Drug Market Size by Country 7.3.1 Europe Metastatic Cancer Treat Drug Sales by Country (2017-2028) 7.3.2 Europe Metastatic Cancer Treat Drug Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Metastatic Cancer Treat Drug Market Size by Type 8.1.1 Asia Pacific Metastatic Cancer Treat Drug Sales by Type (2017-2028) 8.1.2 Asia Pacific Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 8.2 Asia Pacific Metastatic Cancer Treat Drug Market Size by Application 8.2.1 Asia Pacific Metastatic Cancer Treat Drug Sales by Application (2017-2028) 8.2.2 Asia Pacific Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 8.3 Asia Pacific Metastatic Cancer Treat Drug Market Size by Region 8.3.1 Asia Pacific Metastatic Cancer Treat Drug Sales by Region (2017-2028) 8.3.2 Asia Pacific Metastatic Cancer Treat Drug Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Metastatic Cancer Treat Drug Market Size by Type 9.1.1 Latin America Metastatic Cancer Treat Drug Sales by Type (2017-2028) 9.1.2 Latin America Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 9.2 Latin America Metastatic Cancer Treat Drug Market Size by Application 9.2.1 Latin America Metastatic Cancer Treat Drug Sales by Application (2017-2028) 9.2.2 Latin America Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 9.3 Latin America Metastatic Cancer Treat Drug Market Size by Country 9.3.1 Latin America Metastatic Cancer Treat Drug Sales by Country (2017-2028) 9.3.2 Latin America Metastatic Cancer Treat Drug Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Metastatic Cancer Treat Drug Market Size by Type 10.1.1 Middle East and Africa Metastatic Cancer Treat Drug Sales by Type (2017-2028) 10.1.2 Middle East and Africa Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 10.2 Middle East and Africa Metastatic Cancer Treat Drug Market Size by Application 10.2.1 Middle East and Africa Metastatic Cancer Treat Drug Sales by Application (2017-2028) 10.2.2 Middle East and Africa Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 10.3 Middle East and Africa Metastatic Cancer Treat Drug Market Size by Country 10.3.1 Middle East and Africa Metastatic Cancer Treat Drug Sales by Country (2017-2028) 10.3.2 Middle East and Africa Metastatic Cancer Treat Drug Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Roche 11.1.1 Roche Corporation Information 11.1.2 Roche Overview 11.1.3 Roche Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Roche Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Roche Recent Developments 11.2 Merck 11.2.1 Merck Corporation Information 11.2.2 Merck Overview 11.2.3 Merck Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Merck Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Merck Recent Developments 11.3 Johnson and Johnson 11.3.1 Johnson and Johnson Corporation Information 11.3.2 Johnson and Johnson Overview 11.3.3 Johnson and Johnson Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Johnson and Johnson Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Johnson and Johnson Recent Developments 11.4 Eli Lilly 11.4.1 Eli Lilly Corporation Information 11.4.2 Eli Lilly Overview 11.4.3 Eli Lilly Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Eli Lilly Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Eli Lilly Recent Developments 11.5 Sun Pharmaceutical 11.5.1 Sun Pharmaceutical Corporation Information 11.5.2 Sun Pharmaceutical Overview 11.5.3 Sun Pharmaceutical Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Sun Pharmaceutical Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Sun Pharmaceutical Recent Developments 11.6 Bayer 11.6.1 Bayer Corporation Information 11.6.2 Bayer Overview 11.6.3 Bayer Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Bayer Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bayer Recent Developments 11.7 Gilead Sciences 11.7.1 Gilead Sciences Corporation Information 11.7.2 Gilead Sciences Overview 11.7.3 Gilead Sciences Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Gilead Sciences Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Gilead Sciences Recent Developments 11.8 GlaxoSmithKline 11.8.1 GlaxoSmithKline Corporation Information 11.8.2 GlaxoSmithKline Overview 11.8.3 GlaxoSmithKline Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 GlaxoSmithKline Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 GlaxoSmithKline Recent Developments 11.9 Novartis 11.9.1 Novartis Corporation Information 11.9.2 Novartis Overview 11.9.3 Novartis Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Novartis Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Novartis Recent Developments 11.10 Pfizer 11.10.1 Pfizer Corporation Information 11.10.2 Pfizer Overview 11.10.3 Pfizer Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Pfizer Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Pfizer Recent Developments 11.11 AstraZeneca 11.11.1 AstraZeneca Corporation Information 11.11.2 AstraZeneca Overview 11.11.3 AstraZeneca Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 AstraZeneca Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 AstraZeneca Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Metastatic Cancer Treat Drug Industry Chain Analysis 12.2 Metastatic Cancer Treat Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Metastatic Cancer Treat Drug Production Mode & Process 12.4 Metastatic Cancer Treat Drug Sales and Marketing 12.4.1 Metastatic Cancer Treat Drug Sales Channels 12.4.2 Metastatic Cancer Treat Drug Distributors 12.5 Metastatic Cancer Treat Drug Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Metastatic Cancer Treat Drug Industry Trends 13.2 Metastatic Cancer Treat Drug Market Drivers 13.3 Metastatic Cancer Treat Drug Market Challenges 13.4 Metastatic Cancer Treat Drug Market Restraints 14 Key Findings in The Global Metastatic Cancer Treat Drug Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryMarket Analysis and Insights: Global Metastatic Cancer Treat Drug Market Table of Contents1 Study Coverage1.1 Metastatic Cancer Treat Drug Product Introduction 1.2 Market by Type 1.2.1 Global Metastatic Cancer Treat Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Chemotherapy Drugs 1.2.3 Targeted Therapy Drugs 1.3 Market by Application 1.3.1 Global Metastatic Cancer Treat Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Metastatic Cancer Treat Drug Sales Estimates and Forecasts 2017-2028 2.2 Global Metastatic Cancer Treat Drug Revenue Estimates and Forecasts 2017-2028 2.3 Global Metastatic Cancer Treat Drug Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Metastatic Cancer Treat Drug Sales by Region 2.4.1 Global Metastatic Cancer Treat Drug Sales by Region (2017-2022) 2.4.2 Global Sales Metastatic Cancer Treat Drug by Region (2023-2028) 2.5 Global Metastatic Cancer Treat Drug Revenue by Region 2.5.1 Global Metastatic Cancer Treat Drug Revenue by Region (2017-2022) 2.5.2 Global Metastatic Cancer Treat Drug Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Metastatic Cancer Treat Drug Sales by Manufacturers 3.1.1 Global Top Metastatic Cancer Treat Drug Manufacturers by Sales (2017-2022) 3.1.2 Global Metastatic Cancer Treat Drug Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metastatic Cancer Treat Drug in 2021 3.2 Global Metastatic Cancer Treat Drug Revenue by Manufacturers 3.2.1 Global Metastatic Cancer Treat Drug Revenue by Manufacturers (2017-2022) 3.2.2 Global Metastatic Cancer Treat Drug Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Metastatic Cancer Treat Drug Revenue in 2021 3.3 Global Metastatic Cancer Treat Drug Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Metastatic Cancer Treat Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Metastatic Cancer Treat Drug Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Metastatic Cancer Treat Drug Sales by Type 4.1.1 Global Metastatic Cancer Treat Drug Historical Sales by Type (2017-2022) 4.1.2 Global Metastatic Cancer Treat Drug Forecasted Sales by Type (2023-2028) 4.1.3 Global Metastatic Cancer Treat Drug Sales Market Share by Type (2017-2028) 4.2 Global Metastatic Cancer Treat Drug Revenue by Type 4.2.1 Global Metastatic Cancer Treat Drug Historical Revenue by Type (2017-2022) 4.2.2 Global Metastatic Cancer Treat Drug Forecasted Revenue by Type (2023-2028) 4.2.3 Global Metastatic Cancer Treat Drug Revenue Market Share by Type (2017-2028) 4.3 Global Metastatic Cancer Treat Drug Price by Type 4.3.1 Global Metastatic Cancer Treat Drug Price by Type (2017-2022) 4.3.2 Global Metastatic Cancer Treat Drug Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Metastatic Cancer Treat Drug Sales by Application 5.1.1 Global Metastatic Cancer Treat Drug Historical Sales by Application (2017-2022) 5.1.2 Global Metastatic Cancer Treat Drug Forecasted Sales by Application (2023-2028) 5.1.3 Global Metastatic Cancer Treat Drug Sales Market Share by Application (2017-2028) 5.2 Global Metastatic Cancer Treat Drug Revenue by Application 5.2.1 Global Metastatic Cancer Treat Drug Historical Revenue by Application (2017-2022) 5.2.2 Global Metastatic Cancer Treat Drug Forecasted Revenue by Application (2023-2028) 5.2.3 Global Metastatic Cancer Treat Drug Revenue Market Share by Application (2017-2028) 5.3 Global Metastatic Cancer Treat Drug Price by Application 5.3.1 Global Metastatic Cancer Treat Drug Price by Application (2017-2022) 5.3.2 Global Metastatic Cancer Treat Drug Price Forecast by Application (2023-2028) 6 North America 6.1 North America Metastatic Cancer Treat Drug Market Size by Type 6.1.1 North America Metastatic Cancer Treat Drug Sales by Type (2017-2028) 6.1.2 North America Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 6.2 North America Metastatic Cancer Treat Drug Market Size by Application 6.2.1 North America Metastatic Cancer Treat Drug Sales by Application (2017-2028) 6.2.2 North America Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 6.3 North America Metastatic Cancer Treat Drug Market Size by Country 6.3.1 North America Metastatic Cancer Treat Drug Sales by Country (2017-2028) 6.3.2 North America Metastatic Cancer Treat Drug Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada 7 Europe 7.1 Europe Metastatic Cancer Treat Drug Market Size by Type 7.1.1 Europe Metastatic Cancer Treat Drug Sales by Type (2017-2028) 7.1.2 Europe Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 7.2 Europe Metastatic Cancer Treat Drug Market Size by Application 7.2.1 Europe Metastatic Cancer Treat Drug Sales by Application (2017-2028) 7.2.2 Europe Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 7.3 Europe Metastatic Cancer Treat Drug Market Size by Country 7.3.1 Europe Metastatic Cancer Treat Drug Sales by Country (2017-2028) 7.3.2 Europe Metastatic Cancer Treat Drug Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Metastatic Cancer Treat Drug Market Size by Type 8.1.1 Asia Pacific Metastatic Cancer Treat Drug Sales by Type (2017-2028) 8.1.2 Asia Pacific Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 8.2 Asia Pacific Metastatic Cancer Treat Drug Market Size by Application 8.2.1 Asia Pacific Metastatic Cancer Treat Drug Sales by Application (2017-2028) 8.2.2 Asia Pacific Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 8.3 Asia Pacific Metastatic Cancer Treat Drug Market Size by Region 8.3.1 Asia Pacific Metastatic Cancer Treat Drug Sales by Region (2017-2028) 8.3.2 Asia Pacific Metastatic Cancer Treat Drug Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Metastatic Cancer Treat Drug Market Size by Type 9.1.1 Latin America Metastatic Cancer Treat Drug Sales by Type (2017-2028) 9.1.2 Latin America Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 9.2 Latin America Metastatic Cancer Treat Drug Market Size by Application 9.2.1 Latin America Metastatic Cancer Treat Drug Sales by Application (2017-2028) 9.2.2 Latin America Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 9.3 Latin America Metastatic Cancer Treat Drug Market Size by Country 9.3.1 Latin America Metastatic Cancer Treat Drug Sales by Country (2017-2028) 9.3.2 Latin America Metastatic Cancer Treat Drug Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Metastatic Cancer Treat Drug Market Size by Type 10.1.1 Middle East and Africa Metastatic Cancer Treat Drug Sales by Type (2017-2028) 10.1.2 Middle East and Africa Metastatic Cancer Treat Drug Revenue by Type (2017-2028) 10.2 Middle East and Africa Metastatic Cancer Treat Drug Market Size by Application 10.2.1 Middle East and Africa Metastatic Cancer Treat Drug Sales by Application (2017-2028) 10.2.2 Middle East and Africa Metastatic Cancer Treat Drug Revenue by Application (2017-2028) 10.3 Middle East and Africa Metastatic Cancer Treat Drug Market Size by Country 10.3.1 Middle East and Africa Metastatic Cancer Treat Drug Sales by Country (2017-2028) 10.3.2 Middle East and Africa Metastatic Cancer Treat Drug Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Roche 11.1.1 Roche Corporation Information 11.1.2 Roche Overview 11.1.3 Roche Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Roche Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Roche Recent Developments 11.2 Merck 11.2.1 Merck Corporation Information 11.2.2 Merck Overview 11.2.3 Merck Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Merck Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Merck Recent Developments 11.3 Johnson and Johnson 11.3.1 Johnson and Johnson Corporation Information 11.3.2 Johnson and Johnson Overview 11.3.3 Johnson and Johnson Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Johnson and Johnson Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Johnson and Johnson Recent Developments 11.4 Eli Lilly 11.4.1 Eli Lilly Corporation Information 11.4.2 Eli Lilly Overview 11.4.3 Eli Lilly Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Eli Lilly Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Eli Lilly Recent Developments 11.5 Sun Pharmaceutical 11.5.1 Sun Pharmaceutical Corporation Information 11.5.2 Sun Pharmaceutical Overview 11.5.3 Sun Pharmaceutical Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Sun Pharmaceutical Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Sun Pharmaceutical Recent Developments 11.6 Bayer 11.6.1 Bayer Corporation Information 11.6.2 Bayer Overview 11.6.3 Bayer Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Bayer Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bayer Recent Developments 11.7 Gilead Sciences 11.7.1 Gilead Sciences Corporation Information 11.7.2 Gilead Sciences Overview 11.7.3 Gilead Sciences Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Gilead Sciences Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Gilead Sciences Recent Developments 11.8 GlaxoSmithKline 11.8.1 GlaxoSmithKline Corporation Information 11.8.2 GlaxoSmithKline Overview 11.8.3 GlaxoSmithKline Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 GlaxoSmithKline Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 GlaxoSmithKline Recent Developments 11.9 Novartis 11.9.1 Novartis Corporation Information 11.9.2 Novartis Overview 11.9.3 Novartis Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Novartis Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Novartis Recent Developments 11.10 Pfizer 11.10.1 Pfizer Corporation Information 11.10.2 Pfizer Overview 11.10.3 Pfizer Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Pfizer Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Pfizer Recent Developments 11.11 AstraZeneca 11.11.1 AstraZeneca Corporation Information 11.11.2 AstraZeneca Overview 11.11.3 AstraZeneca Metastatic Cancer Treat Drug Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 AstraZeneca Metastatic Cancer Treat Drug Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 AstraZeneca Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Metastatic Cancer Treat Drug Industry Chain Analysis 12.2 Metastatic Cancer Treat Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Metastatic Cancer Treat Drug Production Mode & Process 12.4 Metastatic Cancer Treat Drug Sales and Marketing 12.4.1 Metastatic Cancer Treat Drug Sales Channels 12.4.2 Metastatic Cancer Treat Drug Distributors 12.5 Metastatic Cancer Treat Drug Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Metastatic Cancer Treat Drug Industry Trends 13.2 Metastatic Cancer Treat Drug Market Drivers 13.3 Metastatic Cancer Treat Drug Market Challenges 13.4 Metastatic Cancer Treat Drug Market Restraints 14 Key Findings in The Global Metastatic Cancer Treat Drug Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療/ヘルスケア）の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD（cancer）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
